Perspectives Among Health Care Providers and People with HIV on the Implementation of Long-Acting Injectable Cabotegravir/Rilpivirine for Antiretroviral Therapy in Florida.
Long-acting injectable (LAI) cabotegravir/rilpivirine (CAB/RPV) for antiretroviral therapy (ART) could benefit many people with HIV (PWH). However, its impact will largely be determined by providers' willingness to prescribe it and PWH's willingness to take it. This study explores the perceived barr...
| Publicado en: | AIDS Patient Care & STDs Vol. 38; no. 6; pp. 275 - 286 |
|---|---|
| Autores principales: | , , , , , , , , |
| Formato: | research tables/charts Journal Article |
| Publicado: |
Mary Ann Liebert, Inc.
Jun2024
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=178133110&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 178133110 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 10872914 33C jtl: AIDS Patient Care & STDs issn: 10872914 maglogo: N pubinfo: dt: Jun2024 vid: 38 iid: 6 pid: 1365 pub: Mary Ann Liebert, Inc. place: New Rochelle, New York artinfo: ui: 178133110 178133110 178133110 10.1089/apc.2024.0067 178133110 ppf: 275 ppct: 11 formats: tig: atl: Perspectives Among Health Care Providers and People with HIV on the Implementation of Long-Acting Injectable Cabotegravir/Rilpivirine for Antiretroviral Therapy in Florida. aug: au: Fisk-Hoffman, Rebecca J. Ranger, Sashaun S. Gracy, Abigail Gracy, Hannah Manavalan, Preeti Widmeyer, Maya Leeman, Robert F. Cook, Robert L. Canidate, Shantrel affil: Department of Epidemiology, College of Public Health and Health Professions & College of Medicine, University of Florida, Gainesville, Florida, USA. sug: subj: Attitude of Health Personnel HIV-Positive Persons Psychosocial Factors Patient Attitudes Rilpivirine Therapeutic Use HIV Infections Drug Therapy Anti-HIV Agents Program Implementation Injections Human Adolescence Adult Middle Age Cisgender Persons Male Female Florida Funding Source Health Personnel HIV Infections Epidemiology Semi-Structured Interview White Persons African Americans Hispanic Americans Outpatient Service Thematic Analysis HIV Integrase Inhibitors Drug Resistance Transportation Stigma Health Services Accessibility Insurance, Health Personnel Shortage Workload Qualitative Studies Implementation Science Conceptual Framework Adolescent: 13-18 years Adult: 19-44 years Middle Aged: 45-64 years Male Female ab: Long-acting injectable (LAI) cabotegravir/rilpivirine (CAB/RPV) for antiretroviral therapy (ART) could benefit many people with HIV (PWH). However, its impact will largely be determined by providers' willingness to prescribe it and PWH's willingness to take it. This study explores the perceived barriers and facilitators of LAI CAB/RPV implementation among PWH and HIV care providers in Florida, a high prevalence setting. Semi-structured qualitative interviews were conducted in English with 16 PWH (50% non-Hispanic White, 50% cis men, and 94% on oral ART) and 11 providers (27% non-Hispanic Black, 27% Hispanic, 73% cis women, and 64% prescribed LAI CAB/RPV) throughout the state. Recruitment occurred between October 2022 and October 2023 from HIV clinics. Interviews were recorded, professionally transcribed, and then double coded using thematic analysis. The Consolidated Framework for Implementation Research guided the interview guide and coding. While PWH viewed LAI CAB/RPV as effective, predominant barriers included administration via injection, challenges of attending more clinic visits, and a feeling that this made HIV the center of one's life. Providers additionally expressed concerns about the development of integrase resistance. Barriers noted by PWH and providers outside of the clinic included transportation, stigma, access inequities, and payor issues. Within clinics, providers identified the need for extra staffing and the increased burden on existing staff as barriers. These barriers decreased the perceived need for LAI CAB/RPV among PWH and providers, especially with the high effectiveness of oral ART. Many of the identified barriers occur outside of the clinic and will likely apply to other novel long-acting ART options. pubtype: Academic Journal doctype: research tables/charts Journal Article ougenre: Article language: English refInfo: holdings: @attributes: islocal: N |
|---|